Mary Thistle

Biography

Ms. Thistle received her B.A. degree in accounting from the University of Massachusetts.Ms. Thistle brings extensive experience in the life sciences industry, serving in senior finance, operations, and business development roles. Previously, Ms. Thistle was senior vice president, business development at Cubist Pharmaceuticals.At Cubist, she was responsible for four major acquisitions, including Trius Therapeutics and Optimer Pharmaceuticals, significantly driving growth of the company’s pipeline prior to Cubist’s recent $9.5 billion acquisition by Merck. Prior to this, Ms. Thistle held leadership positions at ViaCell, Inc., including senior vice president, business development, and senior vice president and general manager, ViaCell Reproductive Health. In the latter role, she was responsible for the expansion of the company’s ViaCord™ umbilical blood-banking business, positioning ViaCell for eventual acquisition by PerkinElmer. She also helped set the stage for ViaCell’s successful IPO in her previous role as vice president, finance and corporate planning. Ms. Thistle began her career in finance as a certified public accountant working with both private and public companies. Ms. Thistle received her B.A. degree in accounting from the University of Massachusetts.Ms. Thistle brings extensive experience in the life sciences industry, serving in senior finance, operations, and business development roles. Previously, Ms. Thistle was senior vice president, business development at Cubist Pharmaceuticals.At Cubist, she was responsible for four major acquisitions, including Trius Therapeutics and Optimer Pharmaceuticals, significantly driving growth of the company’s pipeline prior to Cubist’s recent $9.5 billion acquisition by Merck. Prior to this, Ms. Thistle held leadership positions at ViaCell, Inc., including senior vice president, business development, and senior vice president and general manager, ViaCell Reproductive Health. In the latter role, she was responsible for the expansion of the company’s ViaCord™ umbilical blood-banking business, positioning ViaCell for eventual acquisition by PerkinElmer. She also helped set the stage for ViaCell’s successful IPO in her previous role as vice president, finance and corporate planning. Ms. Thistle began her career in finance as a certified public accountant working with both private and public companies.

Research Interest

His research interest in Business and Management